We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$14.6B
AUM Growth
+$1.24B
Cap. Flow
+$998M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.27%
Holding
2,202
New
241
Increased
1,177
Reduced
603
Closed
133

Sector Composition

Rank Sector Weight
1 Energy 9.2%
2 Healthcare 8.03%
3 Technology 7.82%
4 Financials 7.64%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDV
601
iShares Core High Dividend ETF
HDV
$14.8B
$4.69M 0.03%
328,400
-55,225
-14% -$765K
PPH icon
602
VanEck Pharmaceutical ETF
PPH
$988M
$4.69M 0.03%
+80,353
New +$4.54M
AET
603
DELISTED
Aetna Inc
AET
$4.68M 0.03%
62,374
+14,789
+31% +$1.05M
GLO
604
Clough Global Opportunities Fund
GLO
$257M
$4.67M 0.03%
366,509
+321,898
+722% +$4.15M
EEP
605
DELISTED
Enbridge Energy Partners
EEP
$4.67M 0.03%
170,331
-120,907
-42% -$3.38M
FXL icon
606
First Trust Technology AlphaDEX Fund
FXL
$2.79B
$4.66M 0.03%
149,606
+60,414
+68% +$1.86M
NBD
607
DELISTED
Nuveen Build Am Bond Opp Fd
NBD
$4.65M 0.03%
226,971
-5,777
-2% -$116K
AUY
608
DELISTED
Yamana Gold, Inc.
AUY
$4.65M 0.03%
529,554
+30,407
+6% +$294K
MHK icon
609
Mohawk Industries
MHK
$9.22B
$4.63M 0.03%
34,084
-7,004
-17% -$1M
NFLX icon
610
Netflix
NFLX
$309B
$4.63M 0.03%
920,360
-95,340
-9% -$546K
HLF icon
611
Herbalife
HLF
$1.29B
$4.62M 0.03%
161,264
+40,294
+33% +$1.33M
OMC icon
612
Omnicom Group
OMC
$23.4B
$4.61M 0.03%
63,428
-25,508
-29% -$1.88M
ITW icon
613
Illinois Tool Works
ITW
$84.5B
$4.58M 0.03%
56,342
+13,040
+30% +$1.05M
LNC icon
614
Lincoln National
LNC
$8.81B
$4.56M 0.03%
89,918
-4,046
-4% -$203K
UAA icon
615
Under Armour
UAA
$2.6B
$4.56M 0.03%
158,956
+19,808
+14% +$518K
FE icon
616
FirstEnergy
FE
$27.5B
$4.54M 0.03%
133,533
-8,935
-6% -$282K
EA
617
DELISTED
Electronic Arts
EA
$4.53M 0.03%
156,051
+6,612
+4% +$177K
IYE icon
618
iShares US Energy ETF
IYE
$1.7B
$4.53M 0.03%
88,801
+21,536
+32% +$1.06M
SYK icon
619
Stryker
SYK
$130B
$4.5M 0.03%
55,218
+913
+2% +$72.6K
GRX
620
Gabelli Healthcare & Wellness Trust
GRX
$146M
$4.49M 0.03%
449,732
+329,084
+273% +$3.29M
IHE icon
621
iShares US Pharmaceuticals ETF
IHE
$1.64B
$4.49M 0.03%
106,359
+14,793
+16% +$620K
IPHS
622
DELISTED
Innophos Holdings, Inc.
IPHS
$4.49M 0.03%
79,099
+5,155
+7% +$265K
STT icon
623
State Street
STT
$50.7B
$4.47M 0.03%
64,288
+6,005
+10% +$415K
AGN
624
DELISTED
Allergan Inc
AGN
$4.46M 0.03%
35,926
+1,868
+5% +$227K
SPSB icon
625
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
$4.45M 0.03%
144,799
+126,045
+672% +$3.88M

Similar funds

Raymond James & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Raymond James & Associates held 2,202 positions worth $14.6B, up 9.3% from $13.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $998M of net new capital in Q1 2014, opening 241 new positions and adding to 1,177 existing holdings. Its largest new stake was Edgewell Personal Care: 199,912 shares worth $14.9M.

By sector, the portfolio is most concentrated in Energy at 9.2% of assets, down from 9.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vodafone, an estimated $33.9M trimmed.

  • Raymond James & Associates's largest Q1 2014 buy was Edgewell Personal Care: 199,912 shares worth $14.9M.
  • Raymond James & Associates added most to Verizon in Q1 2014, an estimated $31.6M increase.
  • Raymond James & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $33.9M.
  • Raymond James & Associates fully exited Nu Skin in Q1 2014, selling an estimated $5.53M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2014.
  • Raymond James & Associates opened 241 new positions and closed 133 in Q1 2014.
  • Raymond James & Associates's portfolio value rose 9.3% quarter-over-quarter to $14.6B.

Based on Raymond James & Associates's 13F filing for Q1 2014, filed 13 May 2014.